Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
17.44
+0.17 (0.98%)
Jun 18, 2025, 4:00 PM - Market closed
Dianthus Therapeutics Employees
Dianthus Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 25 or 47.17% compared to the previous year.
Employees
78
Change (1Y)
25
Growth (1Y)
47.17%
Revenue / Employee
$83,641
Profits / Employee
-$1,291,436
Market Cap
560.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 78 | 25 | 47.17% |
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
DNTH News
- 21 days ago - Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors - GlobeNewsWire
- 5 weeks ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results - GlobeNewsWire
- 6 weeks ago - Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September - GlobeNewsWire
- 7 weeks ago - Dianthus Therapeutics to Participate in Two Upcoming Investor Events - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors - GlobeNewsWire
- 4 months ago - Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire